The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release ...

Older adults with contrast sensitivity impairment are at greater risk for falls than those without vision problems, a new study found. Researchers from the University of Michigan at Ann Arbor and the ...

Up to 19% of prevalent dementia cases may be attributable to impaired vision, a cross-sectional analysis suggested. Contrast sensitivity impairment showed the strongest relationship, followed by near ...

Monocular contrast sensitivity and microperimetry are useful indicators of visual function and its impact on activities of daily living in those with AMD. Patients with AMD do not rely on binocular ...

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to ...

Across the entire animal kingdom, visual images are processed by two major neuronal pathways that extract light and dark stimuli from visual scenes – ON (light on) and OFF (light off) pathways. Light ...

NASHVILLE, Tenn., June 03, 2021 (GLOBE NEWSWIRE) -- Visionology, a subsidiary of Harrow Health, Inc. (Nasdaq: HROW), an ophthalmic-focused healthcare company, today announced that it had acquired a ...

Researchers also found correlations between contrast sensitivity function and age, HbA1c, and type 1 diabetes (T1D) duration under different lighting conditions. Individuals with type 1 diabetes (T1D) ...

CHICAGO--(BUSINESS WIRE)--Contrast enhanced ultrasound (CEUS) is superior to contrast magnetic resonance (MR) and computed tomography (CT), and offers 100% sensitivity and specificity, for finding ...

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...